fashion -WSS

fashion

author：knowledge 2025-09-05 13:46:20 - browse：515

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： 5 to watch: Tech startups trying to solve health care's staffing crisis

entertainment

WSS

Physicians and social media: If you see something, say something?

Baby aspirin cuts fat buildup in liver disease patients, in small study

Physicians and social media: If you see something, say something?

Will General Catalyst be the first of many hospital takeovers?

Gene editing the human germline: What are the risks?

Free speech concerns arise in wake of journal editor Eisen's firing

focus

fashion

hotspot

Medical records are filled with copy

Asbestos, a deadly carcinogen, banned by EPA

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Victims of gun violence feel impacts long after bullet wound

Moonlake's readout produced a cash windfall. Risks remain

FDA approves Recor Medical high blood pressure device

Supreme Court strikes down use of affirmative action

UnitedHealth increases loan offers after Change Healthcare outage

Continuity nursing helped my family in our darkest PICU moments

A clever new way to fix Medicaid and graduate medical education

Wikipedia

A clever new way to fix Medicaid and graduate medical education

Baby aspirin cuts fat buildup in liver disease patients, in small study

UnitedHealth increases loan offers after Change Healthcare outage

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

MoonLake credibility takes another hit with mid

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

explore

entertainment

leisure time

explore